Catalog Number | CBCL-292 |
Price | Online Inquiry |
Unit Quantity | 1x106 cells / 1.0 ml |
Stable Hep-G2 cell line expressing exogenous human TPBG gene
Drug screening and biological assays
TPBG, also known as 574, is a type I transmembrane glycoprote in that may be involved in cell adhesion, which is an antagonist of Wnt/B-catenin signalling pathway. TPBG is expressed on trophoblasts, tumor cells, ovarian cuboidal epithelium and embryonic stem cells, and impacts cell adhesion and motility. Its confined expression appears to give TPBG the potential to be a target for T cells in cancer immunotherapy.
Species | Human |
Host Cell Line | Hep-G2 |
Cell Type | Human hepatocellular carcinoma cells |
Stability | Stable in culture over 10 passages |
Growth Properties | Adherent |
Pharmaceutical Target | Immune Molecules |
Recommended Medium | RPMI1640 + 10% FBS + 1 μg/ml Puromycin |
Selection Marker | Puromycin |
Morphology | Epithelial |
Seeding Density | Thaw entire contents into an appropriate T25 flask. |
Subculture Ratio | Recommended a ratio of 1:4-1:5. |
Storage Method | Frozen in liquid nitrogen with 70% medium, 20% FBS and 10% DMSO |
Doubling Time | |
QC | WB |
Biosafety Level | BSL-1 |
Shipping | Shipping in dry ice |
Caution | For Research Use Only |